The offer consists of 300 million euros in an immediate cash payment, structured on a cash-free and debt-free basis, with an additional 50 million euros tied to performance milestones extending through 2027. IPG Photonics intends to finance the purchase entirely through existing cash reserves. The acquisition requires a mandatory information and consultation process with Lumibird’s works council, a procedural necessity under French labor regulations, before the parties finalize a definitive agreement.

CEO Mark Gitin stated that the move is designed to create a scaled medical platform capable of accelerating innovation and expanding commercial reach. According to the company, the integration adds roughly $1 billion to its addressable market and is expected to provide an immediate boost to both gross margins and adjusted earnings.